However, the mechanism(s) by which CHI3L1 contributes to tumor development and progression have not been fully defined and the degree to which CHI3L1 contributes to its tumorigenic effects via activating T cell co-stimulators or the CTLA-4-B7 axis have not been investigated. This evidence concerns the gene CD80 and neoplasm.